Nippon India Pharma Fund (Bonus) Equity - Pharma
Plan: OPEN | Option: Growth | Sailesh Raj Bhan
23 Apr 24 | 12:00 AM
420.15 -2.74 (-0.65%)
Critical Parameters
Everyone of us wants to create wealth by investing in top funds. Have a look at the key parameters that you need to check before deciding to invest in a mutual fund.
Returns
In last 1 year Nippon India Pharma Fund (Bonus), has beaten by -5.59% (CAGR difference)
49.20%
Underperforms
This is Alpha
25 Apr 2023
Risk
In last 1 year , the volatility of Nippon India Pharma Fund (Bonus) is Lower than by -0.22%
0.69%
Less Volatile
Risk Meter
Consistency
For 5 out of Last 12 Months, i.e 41.67% of the times It beaten its benchmark, Equity - Pharma
Consistency Meter
Outperforming Stocks Vs. Underperforming Stocks
Based on the last 1year analysis, currently there are, the benchmark the benchmark